Bicalutamide Market

Bicalutamide is a non-steroidal antiandrogenic drug, which is used in combination with luteinizing hormone releasing hormone (LHRH) analogues or surgical orchiectomy in the treatment of advanced prostate cancer.Bicalutamide first by oral absorption good.There is no pharmacodynamic or pharmacokinetic interaction with luteinizing hormone releasing hormone (LHRH) analogues.No interaction with common prescription drugs.No enzyme induction was observed at doses up to 150 mg per day.

Bicalutamide Market contains market size and forecasts of Bicalutamide in global, including the following market information:

Global Bicalutamide Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Bicalutamide Market Sales, 2017-2022, 2023-2028, (M Pcs)

Global top five Bicalutamide companies in 2021 (%)

The global Bicalutamide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bicalutamide include AstraZeneca, CORDEN PHARMA GMBH, Zeneca GmbH, Actavis Pharma, Sivem Pharmaceuticals, Sorres Pharma, Fresenius Kabi, ANI Pharmaceuticals and Accel Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Bicalutamide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bicalutamide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Bicalutamide Market Segment Percentages, by Type, 2021 (%)

Tablets

Capsule

Global Bicalutamide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Bicalutamide Market Segment Percentages, by Application, 2021 (%)

Single Drug For Prostate Cancer

Combined Chemotherapy For Prostate Cancer

Combined Radiation Therapy Or Castration For Prostate Cancer

Global Bicalutamide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Bicalutamide Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bicalutamide revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Bicalutamide revenues share in global market, 2021 (%)

Key companies Bicalutamide sales in global market, 2017-2022 (Estimated), (M Pcs)

Key companies Bicalutamide sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

AstraZeneca

CORDEN PHARMA GMBH

Zeneca GmbH

Actavis Pharma

Sivem Pharmaceuticals

Sorres Pharma

Fresenius Kabi

ANI Pharmaceuticals

Accel Pharma

Apotex Corporation

Shanghai Fudan Fuhua Pharmaceutical

Shanghai Zhaohui Pharmaceutical

Zhejiang Haizheng Pharmaceutical

Shanxi Zhendong Pharmaceutical